Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
Details for Australian Patent Application No. 2002352090 (hide)
International Classifications
Event Publications
20 March 2003 Complete Application Filed
Priority application(s): 02075052.7 02.01.02 EP
4 September 2003 Application Open to Public Inspection
Published as AU-B-2002352090
22 June 2006 Assignment before Grant
Pharmacia Italia S.p.A. The application has been assigned to Nerviano Medical Sciences S.r.l.
15 May 2008 Application Accepted
Published as AU-B-2002352090
19 June 2008 Corrigenda
Applications Accepted - Name Index Under the Name Nerviano Medical Sciences S.r.l., Application No. 2002352090, under the INID (72), correct the name of the co-inventor to Fowst, Camilla
11 September 2008 Standard Patent Sealed
12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002352091-ARTICLES HAVING LOW REFLECTANCE CONDUCTIVE COATINGS WITH CONDUCTIVE COMPONENT OUTERMOST
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser